SIG Programming. Programs sponsored by our 16 SIGs roughout e meeting focus on highly specialized topics in hepatology. Debriefs. Monday – Tuesday. Now offering four  debrief sessions, each providing key highlights from e Liver Meeting. To view e full meeting programming details, visit e Online Program here [Coming Summer ]. TLMdX Schedule. e Liver Meeting Digital Experience (TLMdX) provides access to dozens of educational courses (including flipped learning sessions), oral abstract content from leading researchers around e globe, and Special Interest Group programming on highly specialized topics in hepatology. Download e Program at a Glance (updated as of.13) here or explore our interactive schedule. e Best of e Liver Meeting highlights key presentations from e meeting and provides insights for patient care and ongoing research. Sum y slide ks are provided by topic. e Liver Meeting ePosters. As an all-digital meeting, e Liver Meeting will provide access to most courses — even e ones you can’t attend live — on e TLMdX platform rough February 2021. About AASLD AASLD is e leading organization of scientists and heal care professionals committed to preventing and curing liver disease. LiverLearning, e official eLearning portal of AASLD, offers a variety of online educational resources.Watch full-motion video of presentations from e Liver Meeting and o er meetings – just as if you were in e room! Download PDFs of e slides for fur er study. Hepatitis B 2.0 enduring material is now available. Crediting claiming for is enduring material is available from ober 15, rough ober 14, 2023. Applications for e Liver Meeting Abstract Ads are accepted during e regular abstract submission period. is does not apply to late-breaking abstracts. For more information Abstract Ads and reimbursement policies, visit Travel and Memorial ads or send an email to [email protected] AASLD Membership. AASLD.org. who presented wi new onset ascites from to in a large tertiary care hepatology practice affiliated wi a liver transplant program. Patients were evaluated wi echocardiography, TJ liver biopsy wi HVPG, and analysis of peritoneal fluid. reased serum total bilirubin level from 8.50 ± 0.39. e Best of e Liver Meeting was created by e Scientific Program Committee for e benefit of AASLD members, attendees of e annual conference, and o er clinicians involved in e treatment of liver diseases. e program highlights key presentations from e meeting and provides insights for patient care and ongoing research. Acute Liver Injury and Acute Liver Failure. Alcoholic Liver Disease. e 68 Annual Meeting of e American Association for e Study of Liver Diseases: e Liver Meeting . Pages: i-ii, 1-1253. ober . Previous Issue. Next Issue. GO TO SECTION. Download e AASLD Publications app from e Google Play Store.Missing: programming. Emerging Liver Scholars Now in its eigh year, AASLD Foundation's Emerging Liver Scholars program will host 40 young physicians at e Liver Meeting in Boston. Chosen from a highly qualified applicant pool of 139 individuals, ese trainees have received grants covering travel, housing, and meeting expenses. 08, · Boo 209 for GENFIT / e NASH Education Program TM. e NASH Education Program is attending e Liver Meeting of e American Association for e Study of Liver Diseases (AASLD) in Boston! It’s a great opportunity to meet hepatologists from all over e world. Our team will be ere to introduce e NASH Education Program’s missions. e meeting program is packed wi overlapping sessions and e convention center is packed wi ousands of people. If you don’t know where to begin, you’re feeling anxious or lost, or you just want some great advice, you’ve come to e right place. Use of AASLD Scientific Program Content Information presented during e Liver Meeting is e property of AASLD and e presenter. Information not be recorded, photographed, copied, photocopied, transferred to an electronic format, reproduced or distributed wi out e written permission of AASLD and e presenter. Acute Liver Injury and Acute Liver Failure. Alcoholic Liver Disease. e 60 Annual Meeting of e American Association for e Study of Liver Diseases: e Liver Meeting 2009. Pages: iiA-1246A. 2009. Previous Issue. Next Issue. GO TO SECTION. Export Citation(s) AASLD Program. Pages: 48A-113A. First Published: 23 2009. First. 30, · e final task of e SPC is to place all e sessions into a coherent framework, integrating em wi special symposia, invited speaker sessions, ads ceremonies, debrief sessions, SIG programming, oh and a lunch break, at allows e Liver Meeting attendees to maximize eir educational opportunities and minimize conflict between. Fellows Program. Associate Fellows Program. GI/Transplant Hepatology Pilot Program. Global Outreach & Engagement. Public Policy. Viral Hepatitis Elimination: Call to Action. AASLD’s 70 Anniversary. Cirrhosis Quality Collaborative. Emerging Liver Scholars Program. Research and Career Development Ads. Year of e Nurse. As between AASLD and any institution, AASLD is e owner of all AASLD programming and AASLD does not relinquish any such ownership rights by virtue of is Limited License. AASLD disclaims all ranties, express and implied, as to any information or materials presented in connection wi any AASLD session or meeting, including as. View select captured content from e Liver Meeting in San Francisco, CA. Acute on Chronic Liver Failure SIG: e Role of Infection in e Development of ACLF Alcoholic Liver Disease and Public Heal /Heal Care Delivery SIGs: Alcoholic Liver Disease: Policy & Practice. American Association for e Study of Liver Disease (AASLD) is organizing e Liver Meeting . Date of event Friday 8 ember to Tuesday 12 ember . Location John B. Hynes Memorial Convention Center Boston, Massachusetts (United States) Continuing Education Credits Pharmacology, CME, CE, ABIM MOC, ABP MOC. View e online program. All poster presenters of e Liver Meeting Digital Experience are required to: Register for and attend e Annual Meeting*. Review and comply wi all AASLD Faculty Agreement and Presentation Guidelines. Indicate all relevant financial disclosures on e bottom right-hand corner of your poster. e Liver Meeting provides cutting-edge programming at specifically targets e diverse needs of hepatology professionals. Attendees can expect to learn e most up-to-date clinical and basic research trends in liver disease from renowned experts in e field. 02, · SEATTLE, . 2, /PRNewswire/ Seal Rock erapeutics, Inc., a preclinical stage company developing first-in-class and best-in-class treatments for severe liver diseases wi limited or no. Information presented during e Liver Meeting Digital Experience is e property of AASLD and e presenter. Information not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, posted on ano er forum, linked to, or distributed wi out e written permission of AASLD and e presenter. 15, · e Best of e Liver Meeting – Official Slide Sets Now Available We are announcing a new AASLD program for members and attendees of e Liver Meeting at features a single slide sum y of over 0 key presentations from e Liver Meeting in PowerPoint format. is also includes e complete abstract for each sum y [ ]. 02, · Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at e AASLD e Liver Meeting Digital Experience ember 2, at 8:00 AM EST. AASLD encourages you to make e most out of your member benefits. Member rates and early access to registration and housing are benefits offered to AASLD members when you register for e Liver Meeting. To qualify, membership must be current at e time of registration. Please take a moment to renew your membership. AASLD is pleased to announce a new program aimed at distinguishing e professional achievements of advance care providers and o er allied heal professionals. Introducing e Associate Fellows of e American Association for e Study of Liver Disease (AF-AASLD) designation. 02, · Inventiva announces e additional acceptance of two late-breaking abstracts at e AASLD e Liver Meeting Digital Experience PRESS RELEASE GlobeNewswire . . 02, · ese ree abstracts complement Inventiva's presence at e AASLD e Liver Meeting Digital Experience , where Inventiva had already been selected for an oral plenary presentation of e. 01, · Metacrine to Present New Data from MET409 Program in NASH at AASLD’s e Liver Meeting Digital Experience e virtual meeting is taking place . 13-16, .Au or: Metacrine, Inc. Viral Hepatitis Program Director at e Centers for Disease Control and Prevention Dr. Carolyn Wester has ided to support e COVID-19 response full time rough e 5. Dr. Wester is deploying as a Co-Deputy Incident Manager, overseeing e Community & Heal Systems Task Forces. Metacrine to Present New Data from MET409 Program in NASH at AASLD's e Liver Meeting Digital Experience will be presented at e American Association for e Study of Liver Diseases. 01, · Metacrine to Present New Data from MET409 Program in NASH at AASLD’s e Liver Meeting Digital Experience New Data Support Robust, Sustained FXR Activation by MET409 in Patients wi NASH. 02, · is annual meeting of e American Association for e Study of Liver Diseases (AASLD) will be hosted virtually ember 13-16, . TLMdX Poster Presentations. e American Association for e Study of Liver Diseases (AASLD) is e leading organization of scientists and heal care professionals committed to preventing and curing liver disease.Missing: programming. 02, · ese ree abstracts complement Inventiva’s presence at e AASLD e Liver Meeting Digital Experience , where Inventiva had already been selected for an oral plenary presentation of e. 28, · AASLD fosters research at leads to improved treatment options for millions of liver disease patients. AASLD advances e science and practice of hepatology rough educational conferences, training programs, professional publications, and partnerships wi government agencies and sister societies. About lanifibranor. 02, · -Final PEDFIC 1 and interim PEDFIC 2 resultsacceptedat AASLD’s e Liver Meeting PEDFIC1 andPEDFIC 2: largest global Phase 3 in children wi PFIC types 1,2&3- . 02, · -Final PEDFIC 1 and interim PEDFIC 2 results accepted at AASLD’s e Liver Meeting PEDFIC 1 and PEDFIC 2: largest global Phase 3 in children wi PFIC types 1, 2 & 3 Two abstracts to be presented on new pipeline compound-BOSTON, . 02, (GLOBE NEWSWIRE) Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing el .